News Focus
News Focus
Followers 59
Posts 2267
Boards Moderated 0
Alias Born 02/13/2016

Re: sts66 post# 163725

Thursday, 11/29/2018 6:30:22 AM

Thursday, November 29, 2018 6:30:22 AM

Post# of 447187

No. ANCHOR is dead. CRL said AMRN had 1 yr to respond with the requested additional info, and if it was not received in time the sNDA would be considered withdrawn (AMNR may have had option to ask for short extension, but they didn't, no point). I have the CRL PDF stashed somewhere, but don't need to find it and look it up - that 1 yr timeline stuck out like a sore thumb, impossible to forget.


STS, thanks but I really think your memory on this point may be faulty.

Many resubmissions occur after a year, it would be arbitrary and capricious for the FDA to impose something like that on Amarin.

Many drugs are approved after their second (or later) review cycle and are more than a year from the CRL.

I think it more likely the 1 year reference you recall relates to how long they had to file a complaint (push it up the chain). And they did that (IIRC) a couple times.

I sure would love to see that CRL. I'll have to check my other computer to see if I saved it (it was shared on IV 3 years ago).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News